case_images: PMC11830594_01
case_images: (A) MRI of the brain shows brain metastases. (B) MRI of the abdomen shows liver metastatic lesions. (C) MRCP performed when TB level was re-increased showing normal biliary tract. (D) Summary of clinical course and biochemical examinations.
case_images: fonc-15-1385794-g001.jpg
case_images: PMC11830594_01_fonc-15-1385794-g001.jpg
case_images: f1
case_images: Liver function tests were conducted revealing the following results: total bilirubin (TB): 136 mumol/L (normal range: 0-26 mumol/L), alanine transaminase (ALT): 526 U/L (normal range: 0-50 U/L), aspartate transaminase (AST): 350 U/L (normal range: 0-40 U/L), alkaline phosphatase (ALP): 362 U/L (normal range: 45-125 U/L), and gamma-glutamyl transpeptidase (GTP): 264 U/L (normal range: 10-60 U/L) ( Figure 1D ). Pulmonary imaging examination revealed stable disease, and magnetic resonance imaging (MRI) detected brain metastasis ( Figure 1A ). MRI revealed multiple small metastatic liver lesions, with the largest lesion diameter being approximately 1 centimeter. Magnetic resonance cholangiopancreatography (MRCP) did not show any signs of biliary tract obstruction on the 93rd day ( Figures 1B, C ).